MERT, K. U. 2022. Diabetic Dyslipidemia (Which Lipid Parameter Should be Our Target: LDL, non-HDL, ApoB?). EAS 6th Update in Clinical Lipidology .

MERT, K. U., (2022). Diabetic Dyslipidemia (Which Lipid Parameter Should be Our Target: LDL, non-HDL, ApoB?) . EAS 6th Update in Clinical Lipidology

MERT, KADİR. "Diabetic Dyslipidemia (Which Lipid Parameter Should be Our Target: LDL, non-HDL, ApoB?)," EAS 6th Update in Clinical Lipidology, 2022

MERT, KADİR U. . "Diabetic Dyslipidemia (Which Lipid Parameter Should be Our Target: LDL, non-HDL, ApoB?)." EAS 6th Update in Clinical Lipidology , 2022

MERT, K. U. (2022) . "Diabetic Dyslipidemia (Which Lipid Parameter Should be Our Target: LDL, non-HDL, ApoB?)." EAS 6th Update in Clinical Lipidology .

@conferencepaper{conferencepaper, author={KADİR UĞUR MERT}, title={Diabetic Dyslipidemia (Which Lipid Parameter Should be Our Target: LDL, non-HDL, ApoB?)}, congress name={EAS 6th Update in Clinical Lipidology}, city={}, country={}, year={2022}}